在暴露于铜纳米颗粒的草鱼中亚细胞分裂的贝叶斯毒动力学建模及其对解毒的影响
Hsing-Chieh Lin1, Yu-Lin Tsai2, Bing-Ru Hsiao2
1Department of Ecology and Environmental Resources, National University of Tainan, Tainan, Taiwan.
铜纳米颗粒 (CuNPs) 的颗粒大小影响了草中铜的积累. 较小的CuNPs导致较低剂量的较高积累,而较大的CuNPs显示更快的吸收,影响水生纳米毒理学风险评估.
科学领域:
- 环境毒理学环境毒理学
- 纳米毒理学研究
- 水生生态毒理学 水生生态毒理学
背景情况:
- 评估纳米材料的生态毒理风险需要了解水生生物中的纳米粒子积累.
- 铜纳米粒子 (CuNPs) 越来越普遍,需要对其环境命运和影响进行研究.
研究的目的:
- 评估铜纳米颗粒 (CuNP) 颗粒大小对草 (Ctenopharyngodon idellus) 铜 (Cu) 亚细胞分区动力学的影响.
- 使用贝叶斯的两分区毒动力学 (TK) 模型来量化Cu吸收,解毒和消除率.
主要方法:
- 草暴露于CuNPs (40-60nm和60-80nm) 的不同度 (0.03,0.1,0.3μg mL-1) 在10天内.
- 用贝叶斯马尔科夫链蒙特卡洛 (MCMC) 模拟来估计毒动力学速率常数 (kuA,kd,ke) 并量化不确定性.
主要成果:
- 较小的CuNP导致低到中等度的肝脏和脏中的Cu积累更大,可能是由于度更高的聚合.
- 贝叶斯式TK模型表明了组织特异性的动力学:较大的CuNP显示了更快的吸收,而较小的颗粒提高了排毒率,特别是在肝脏和肠道.
- 粒子大小和度通过排毒机制动态影响Cu亚细胞命运.
结论:
- 贝叶斯式MCMC亚细胞分区TK模型增强了对水生纳米毒理学中的粒子大小效应的理解.
- 粒子特性和暴露水平是评估水生生态系统中CuNPs的生物反应和环境风险的关键因素.
更多相关视频
16:21Quantifying Fish Swimming Behavior in Response to Acute Exposure of Aqueous Copper Using Computer Assisted Video and Digital Image Analysis
Published on: February 26, 2016
09:43Protocol for Acute and Chronic Ecotoxicity Testing of the Turquoise Killifish Nothobranchius furzeri
Published on: April 24, 2018
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Extraction: Advanced Methods
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
